| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |